Cryopreservation impairs cytotoxicity and migration of NK cells in 3-D tissue: Implications for cancer immunotherapy

Christoph Mark, Tina Czerwinski, Susanne Roessner, Astrid Mainka, F Horsch, Lucas Heublein, Alexander Winterl, Sebastian Sanokowski, Sebastian Richter, Nina Bauer, Gerold Schuler, Ben Fabry, Caroline VoskensbioRxiv 2019 · DOI

TL;DR

Cryopreservation, a standard procedure for storing NK cells for cancer immunotherapy, significantly impairs their ability to migrate and kill cancer cells in a 3D tissue environment. This reduced motility, rather than a loss of intrinsic killing ability, appears to be the primary reason for the poor success rates of NK cell therapies against solid tumors.

What Problem Does This Paper Address?

Adoptive transfer of Natural Killer (NK) cells holds promise for cancer immunotherapy, particularly against solid tumors. However, clinical trials have largely been unsuccessful. A critical step in preparing NK cells for clinical use involves cryopreservation to bridge the time needed for safety evaluations. While standard assays suggest cryopreserved NK cells retain their killing ability, their ineffectiveness in solid tumors suggests a disconnect between lab results and in vivo function. This paper investigates whether cryopreservation impacts NK cell function in a more physiologically relevant 3D environment, specifically their ability to migrate and kill cancer cells within simulated tissue.

Methods

The researchers employed a multi-pronged approach:

  • Standard Assays: They used CD107a degranulation assays to assess NK cell's ability to release cytotoxic granules and chromium-release assays to measure direct tumor cell killing.
  • 3D Collagen Gel Model: To mimic the tumor microenvironment, they embedded NK cells and K562 cancer cells within 3D collagen gels.
  • Time-Lapse Imaging: High-resolution, time-lapse microscopy was used to track individual NK cell movements and interactions with cancer cells over extended periods within the 3D gels.
  • Convolutional Neural Networks (CNNs): A custom-trained CNN was developed for automated detection and tracking of NK cells and their migration trajectories within the 3D images. This allowed for quantitative analysis of motility parameters like speed and persistence.
  • 3D Cytotoxicity Assay: This assay, performed within the 3D collagen gel, quantified the killing of K562 cells by NK cells over time, allowing for the estimation of killing rates.

Datasets

Not explicitly detailed as distinct datasets for training/evaluation in the traditional machine learning sense. The primary "dataset" is the experimental data generated from the 3D collagen gel experiments, which was then used to train the custom CNN for cell tracking and analysis.

Key Insights and Ideas

  • Motility is Key in 3D: The paper strongly suggests that NK cell migration in a 3D environment is crucial for their cytotoxic function against solid tumors, a factor not fully captured by traditional 2D assays.
  • Cryopreservation's Hidden Impact: While cryopreservation doesn't abolish NK cell's intrinsic killing machinery (as shown by degranulation assays), it severely cripples their ability to move and reach cancer cells in a tissue-like setting.
  • Motility Directly Correlates with Cytotoxicity: The study found a clear power-law relationship between the fraction of motile NK cells and their cytotoxic capacity in 3D gels, reinforcing the link between movement and killing.
  • 3D Assays are More Predictive: The findings highlight that 3D assays, which incorporate cell migration, provide a more accurate prediction of NK cell function in vivo compared to standard 2D assays.

Key Results

  • 6-fold Decrease in Motility: Cryopreservation led to a dramatic 6-fold reduction in the fraction of motile NK cells in 3D collagen gels.
  • 5.6-fold Decrease in Composite Cytotoxicity: When considering both motile and non-motile cells in the 3D environment, cryopreserved NK cells showed a 5.6-fold decrease in overall killing efficiency.
  • Retained Intrinsic Killing: Degranulation assays showed no significant difference in the ability of cryopreserved NK cells to release cytotoxic granules compared to fresh cells.
  • Chromium-Release Assay Decline: A statistically significant decrease in cytotoxicity was observed in chromium-release assays after cryopreservation.
  • Motile Cells Retain Function: The small population of NK cells that remained motile after cryopreservation retained their cytotoxic function.
  • Correlation in 3D: Cytotoxicity in 3D gels increased with the motile fraction, with a power-law relationship (R² ≥ 0.42) observed across different NK-to-target cell ratios.

Limitations and Future Work

  • Oversimplification of Killing Kinetics: The authors acknowledge that assuming a constant killing efficiency and constant concentration of motile NK cells over the 15-hour observation period is an oversimplification.
  • Potential Overestimation of Killing Rate: The study noted a potential overestimation of the killing rate by up to 10% due to false negatives in cell death classification.
  • Future Directions: The paper strongly suggests that future NK cell therapy strategies should focus on preserving or enhancing NK cell motility, and that 3D in vitro models are essential for better predicting in vivo efficacy. Further research could explore methods to improve NK cell motility post-cryopreservation or investigate alternative cell preparation techniques.

Summary updated

Abstract

Abstract Natural killer (NK) cells are important effector cells in the immune response to cancer. Clinical trials on adoptively transferred NK cells in patients with solid tumors, however, have thus far been unsuccessful. As NK cells need to pass stringent safety evaluation for clinical use, the cells are cryopreserved to bridge the necessary evaluation time. While a degranulation assay confirms the ability of cryopreserved NK cells to kill target cells, we find a significant decrease of cytotoxicity after cryopreservation in a chromium release assay. We complement these standard assays with measurements of NK cell motility and cytotoxicity in 3-dimensional (3-D) collagen gels that serve as a substitute for connective tissue. We find a 5.6 fold decrease of cytotoxicity after cryopreservation and establish that this is mainly caused by a 6-fold decrease in the fraction of motile NK cells. These findings may explain the persistent failure of NK cell therapy in patients with solid tumors and highlight the crucial role of a 3-D environment for testing NK cell function. Synopsis Cryopreservation of natural killer (NK) cells dramatically impairs their motility and cytotoxicity in tissue. This finding may explain the persistent failure of clinical trials in which NK cell therapy is used for treating solid tumors.
BibTeX
@misc{mark2019cryopreservation,
  author = {Christoph Mark and Tina Czerwinski and Susanne Roessner and Astrid Mainka and F Horsch and Lucas Heublein and Alexander Winterl and Sebastian Sanokowski and Sebastian Richter and Nina Bauer and Gerold Schuler and Ben Fabry and Caroline Voskens},
  title = {{Cryopreservation impairs cytotoxicity and migration of NK cells in 3-D tissue: Implications for cancer immunotherapy}},
  year = {2019},
  doi = {10.1101/812172},
  howpublished = {bioRxiv},
}
Figure